ATE451933T1 - Wirkstoff zur erhöhung der anzahl an dendritischen vorläuferzellen im blut - Google Patents
Wirkstoff zur erhöhung der anzahl an dendritischen vorläuferzellen im blutInfo
- Publication number
- ATE451933T1 ATE451933T1 AT03756720T AT03756720T ATE451933T1 AT E451933 T1 ATE451933 T1 AT E451933T1 AT 03756720 T AT03756720 T AT 03756720T AT 03756720 T AT03756720 T AT 03756720T AT E451933 T1 ATE451933 T1 AT E451933T1
- Authority
- AT
- Austria
- Prior art keywords
- blood
- dendritic
- dendritic cells
- increase
- dendritic cell
- Prior art date
Links
- 239000002243 precursor Substances 0.000 title abstract 4
- 210000004369 blood Anatomy 0.000 title abstract 2
- 239000008280 blood Substances 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 title 1
- 210000004443 dendritic cell Anatomy 0.000 abstract 6
- 210000005259 peripheral blood Anatomy 0.000 abstract 2
- 239000011886 peripheral blood Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000003028 elevating effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002310090 | 2002-10-24 | ||
| JP2003170091A JP2004196770A (ja) | 2002-10-24 | 2003-06-13 | 樹状細胞前駆体の血中レベル上昇剤 |
| PCT/JP2003/013416 WO2004037288A1 (ja) | 2002-10-24 | 2003-10-21 | 樹状細胞前駆体の血中レベル上昇剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE451933T1 true ATE451933T1 (de) | 2010-01-15 |
Family
ID=32179095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03756720T ATE451933T1 (de) | 2002-10-24 | 2003-10-21 | Wirkstoff zur erhöhung der anzahl an dendritischen vorläuferzellen im blut |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20060210531A1 (de) |
| EP (1) | EP1563847B1 (de) |
| JP (1) | JP2004196770A (de) |
| KR (1) | KR100786458B1 (de) |
| AT (1) | ATE451933T1 (de) |
| AU (1) | AU2003301653B2 (de) |
| CA (1) | CA2505597A1 (de) |
| DE (1) | DE60330595D1 (de) |
| TW (1) | TW200406219A (de) |
| WO (1) | WO2004037288A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101119743B (zh) * | 2005-01-31 | 2012-09-26 | 株式会社Eci | 免疫增强剂 |
| WO2007037069A1 (ja) * | 2005-09-27 | 2007-04-05 | Sumitomo Bakelite Company, Ltd. | 医療用粒子及びその製造方法 |
| JP2011001273A (ja) * | 2009-06-16 | 2011-01-06 | Eci Inc | ｅＭＩＰを有効成分とする水溶性製剤 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5616688A (en) * | 1981-09-08 | 1997-04-01 | The Rockefeller University | Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β) |
| JPS6483548A (en) * | 1987-09-25 | 1989-03-29 | Matsushita Electric Industrial Co Ltd | Mixing and crushing of ceramic powder |
| US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
| WO1993013206A1 (en) * | 1991-12-23 | 1993-07-08 | British Bio-Technology Limited | Stem cell inhibiting proteins |
| AU6974294A (en) * | 1993-06-15 | 1995-01-03 | British Biotech Pharmaceuticals Limited | Release and mobilisation of haematopoietic cells |
| US5824784A (en) * | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
| JP4067058B2 (ja) * | 1995-03-10 | 2008-03-26 | 中村 敏一 | Ｐｅｇ化ｈｇｆ |
| US5788963A (en) * | 1995-07-31 | 1998-08-04 | Pacific Northwest Cancer Foundation | Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| AU1119397A (en) * | 1995-11-14 | 1997-06-05 | Regents Of The University Of Minnesota | Ex vivo culture of stem cells |
| US6168784B1 (en) * | 1997-09-03 | 2001-01-02 | Gryphon Sciences | N-terminal modifications of RANTES and methods of use |
| EP1013276A1 (de) * | 1998-12-23 | 2000-06-28 | Pfizer Inc. | Aminoazacycloalkane als CCR5-Modulatoren |
| ATE412433T1 (de) * | 1999-02-12 | 2008-11-15 | Scripps Research Inst | Methoden zur behandlung von tumoren und metastasen unter verwendung einer anti-angiogenen und immun-therapien |
| US7091310B2 (en) * | 2002-09-13 | 2006-08-15 | Chemokine Therapeutics Corporation | Chemokine analogs for the treatment of human disease |
| WO2001083548A1 (en) * | 2000-04-28 | 2001-11-08 | Effector Cell Institute | Novel derivative of cell chemotactic factor |
| JP5000050B2 (ja) * | 2001-08-31 | 2012-08-15 | 浩 前田 | 抗腫瘍剤及びその製造方法 |
-
2003
- 2003-06-13 JP JP2003170091A patent/JP2004196770A/ja active Pending
- 2003-10-13 TW TW092128319A patent/TW200406219A/zh unknown
- 2003-10-21 AT AT03756720T patent/ATE451933T1/de not_active IP Right Cessation
- 2003-10-21 US US10/531,580 patent/US20060210531A1/en not_active Abandoned
- 2003-10-21 WO PCT/JP2003/013416 patent/WO2004037288A1/ja not_active Ceased
- 2003-10-21 KR KR1020057007161A patent/KR100786458B1/ko not_active Expired - Fee Related
- 2003-10-21 CA CA002505597A patent/CA2505597A1/en not_active Abandoned
- 2003-10-21 DE DE60330595T patent/DE60330595D1/de not_active Expired - Lifetime
- 2003-10-21 EP EP03756720A patent/EP1563847B1/de not_active Expired - Lifetime
- 2003-10-21 AU AU2003301653A patent/AU2003301653B2/en not_active Ceased
-
2007
- 2007-06-25 US US11/819,147 patent/US20080124307A1/en not_active Abandoned
-
2009
- 2009-09-04 US US12/554,676 patent/US20100021442A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004037288A1 (ja) | 2004-05-06 |
| AU2003301653B2 (en) | 2008-02-28 |
| CA2505597A1 (en) | 2004-05-06 |
| AU2003301653A1 (en) | 2004-05-13 |
| KR100786458B1 (ko) | 2007-12-17 |
| EP1563847A4 (de) | 2008-01-02 |
| KR20050083823A (ko) | 2005-08-26 |
| JP2004196770A (ja) | 2004-07-15 |
| DE60330595D1 (de) | 2010-01-28 |
| US20080124307A1 (en) | 2008-05-29 |
| US20100021442A1 (en) | 2010-01-28 |
| EP1563847B1 (de) | 2009-12-16 |
| TW200406219A (en) | 2004-05-01 |
| EP1563847A1 (de) | 2005-08-17 |
| US20060210531A1 (en) | 2006-09-21 |
| AU2003301653A2 (en) | 2004-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2009112207A (ru) | Конкретное глюкокортикостероидное соединение, обладающее противовоспалительной активностью | |
| SV2002000245A (es) | Oxazolidinonas substituidas y su uso ref. lea 34122-sv | |
| UY29321A1 (es) | Piperazinilureas y piperidinilureas como moduladores de hidrolasa de amida de ácidos grasos | |
| EA200800161A1 (ru) | Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций | |
| NO20034684L (no) | Mikroprojeksjonsanordning med belegg inneholdende et fordelaktig middel | |
| MY167123A (en) | Conveniently implantable sustained release drug compositions | |
| EP2168962A3 (de) | Phenylacetamide und ihre Verwendung als Glucokinase-Modulatoren | |
| EA200900087A1 (ru) | Применение гидрофильной матрицы, содержащей производное полиакриловой кислоты, простой эфир целлюлозы и дезинтегрирующий агент, в производстве медикаментов для лечения заболеваний женских гениталий | |
| WO2005077950A3 (en) | Medicaments with hm74a receptor activity | |
| PA8748101A1 (es) | Benzoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus | |
| CY1111465T1 (el) | Εμφυτευσιμη πολυμερικη ιατροτεχνολογικη συσκευη για κατακρατημενη αποδεσμευση του αγωνιστη δοπαμινης | |
| MX2007004882A (es) | Derivados de xantina con actividad de receptor de hm74a. | |
| CY1109229T1 (el) | Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο | |
| BR0308137A (pt) | Formulações de droga de liberação constante contendo um peptìdeo veìculo | |
| WO2004019921A3 (en) | Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases | |
| NO20081253L (no) | Klebepreparat inneholdende bisopropol | |
| SE0100158D0 (sv) | Novel method and composition for local treatment of Meniere´s disease and tinnitus | |
| CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
| Touni et al. | Melanocyte-keratinocyte cross-talk in vitiligo | |
| CY1108992T1 (el) | Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας | |
| WO2005016867A3 (en) | Anthranilic acid derivatives and their use as activators of the hm74a receptor | |
| DK2613784T3 (da) | Indretning til transdermal indgivelse af lægemiddel | |
| DK1699480T3 (da) | Allogent terapeutisk tumormiddel | |
| TR200401603T4 (tr) | D vitamini benzerleri | |
| DE60215866D1 (de) | Medikament, enthaltend cyanidin-3-glykosid als wirkstoff gegen fettsucht und diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |